Company Analysis ORIC Pharmaceuticals, Inc.
1. Summary
Advantages
- The stock's return over the last year (75.48%) is higher than the sector average (-2.81%).
Disadvantages
- Price (8.23 $) is higher than fair price (6.83 $)
- Dividends (0%) are below the sector average (0.544%).
- Current debt level 1.16% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-54.73%) is lower than the sector average (ROE=109.03%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| ORIC Pharmaceuticals, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 2.4% | -13.3% | -1.6% |
| 90 days | -31.9% | -2.3% | 1.7% |
| 1 year | 75.5% | -2.8% | 20.4% |
ORIC vs Sector: ORIC Pharmaceuticals, Inc. has outperformed the "Healthcare" sector by 78.29% over the past year.
ORIC vs Market: ORIC Pharmaceuticals, Inc. has outperformed the market by 55.12% over the past year.
Stable price: ORIC is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ORIC with weekly volatility of 1.45% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (8.23 $) is higher than the fair price (6.83 $).
Price is higher than fair: The current price (8.23 $) is 17% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-5.36) is higher than that of the sector as a whole (-205.4).
P/E vs Market: The company's P/E (-5.36) is higher than that of the market as a whole (-65.33).
5.3. P/BV
P/BV vs Sector: The company's P/BV (2.31) is lower than that of the sector as a whole (245).
P/BV vs Market: The company's P/BV (2.31) is lower than that of the market as a whole (50.62).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (61.67).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (138.73).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-4) is lower than that of the sector as a whole (12.25).
EV/Ebitda vs Market: The company's EV/Ebitda (-4) is higher than that of the market as a whole (-48.34).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 12.37% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (12.37%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-609.67%).
6.4. ROE
ROE vs Sector: The company's ROE (-54.73%) is lower than that of the sector as a whole (109.03%).
ROE vs Market: The company's ROE (-54.73%) is lower than that of the market as a whole (-10.16%).
6.6. ROA
ROA vs Sector: The company's ROA (-48.6%) is lower than that of the sector as a whole (-2.42%).
ROA vs Market: The company's ROA (-48.6%) is lower than that of the market as a whole (40.05%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-32.1%) is lower than that of the sector as a whole (0.8343%).
ROIC vs Market: The company's ROIC (-32.1%) is lower than that of the market as a whole (8.78%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.544%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
9. Insider trades
9.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
9.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 16.12.2025 | Chacko Jacob Officer |
Purchase | 9.06 | 30 237 | 33 374 |
| 16.12.2025 | Multani Pratik S Officer |
Purchase | 9.06 | 9 712 | 10 720 |
| 16.12.2025 | Piscitelli Dominic Officer |
Purchase | 9.06 | 9 712 | 10 720 |
| 03.10.2025 | Heyman Richard A. Director |
Purchase | 1.69 | 55 432 | 32 800 |
| 01.10.2025 | Chacko Jacob PRESIDENT AND CEO |
Sale | 12.05 | 638 662 | 53 001 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
